Table 3. Upregulation in the candidate of TGC-specific AIs in cancer cells or tumors under the previous reports.

Name of AIs	Materials	Methods	Related cancer or tumor	value of fold	Reference
Tubb2c	Epstein-Barr virus (EBV) + Raji cell line (Endemic Burkitt lymphoma) EBV + NC37 cell line EBV – Ramos cell line (Sporadic Burkitt lymphoma)	Mass spectrometry-based isotope tag for relative and absolute quantitation (iTRAQ)	Burkitt lymphoma	5.2	79
Tubb2c	HEC-1A cell line	Mass spectrometry	Endometrial cancer cells	not shown	80
Tubb2c	Bone marrow cell	Gene expression microarray	Myelodysplastic syndrome	not shown	81
Atp6v1a	—	—	—	—	—
Pdhb	DLD1 cell line	Real-time PCR	Colon carcinoma	1.5	82
Pdhb	Non-side population in 50 CNE-2 single cell	Northern blot	Nasopharyngeal carcinoma	not shown	83
Hsc70t	Hepatocellular carcinoma cell	Gene expression microarray	Hepatocellular carcinoma	1.1	84
Hsc70t	A375 metastatic melanoma cell line	RT2 Human Stress and Toxicity Profiler™ PCR Expression Array	Melanoma	16.9	85
Fbp1	C666, CNE2, S18, S26, SUNE2, 5-8F, 6-10B, SUNE1, CNE1, HNE1, HK1 and HONE1 (NPC cell lines)	Western blot	Nasopharyngeal carcinoma	2.8, 5.6, 3.1, 2.3, 2.9, 1.7, 3, 4.1, 2.9, 3.3, 2.5, 2.9	86
Fbp1	Pancreatic cancer cell lines (Panc-1, Bxpc-3, Aspc-1)	Real-time PCR	Pancreatic cancer	2.5	87
Fbp1	Hepatocellular carcinoma cell MH14 cell line	Immunohistochemistry and Oncomine data analysis (mRNA expression)	Hepatocellular carcinoma (with chronic hepatitis C)	4	88
Fbp1	Glioma cell	Western blot	Glioma	2	89
Fbp1	Lung cancer cell	Mass spectrometry	Lung cancer	2.5	90
Fbp1	CCLP1 human liver cancer cell line	Western blot	Liver cancer	1.72	91
Fbp1	Bladder urothelial carcinoma tissue	Immunohistochemistry	Bladder urothelial carcinoma	not shown	92
Lrrc34	—	—	—	—	—
Dnpep	—	—	—	—	—
Gapdhs	—	—	—	—	—
Pdha2	—	—	—	—	—
Dazap1	—	—	—	—	—
Unnamed protein	—	—	—	—	—